Shattuck Labs (STTK) Interest & Investment Income (2019 - 2026)
Shattuck Labs' (STTK) quarterly Interest & Investment Income came in at $779000.0 in Q1 2026, up 13.06% year-on-year from $689000.0 in Q1 2025, and up 13.06% on a QoQ basis from $689000.0 in Q1 2025.
Shattuck Labs (STTK) Interest & Investment Income (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 5 years of Interest & Investment Income data on file, last reported at $779000.0 in Q1 2026.
- On a quarterly basis, Interest & Investment Income rose 13.06% year-over-year to $779000.0 in Q1 2026; TTM through Mar 2026 was $397000.0, a 35.76% decrease from a year earlier, with the FY2025 full-year figure at $2.7 million, down 47.76% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $779000.0, up from $689000.0 in the prior quarter.
- Over the last five years, Interest & Investment Income for STTK reached as high as $779000.0 in Q1 2026 and fell as low as $689000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Shattuck Labs | 831.66 Mn | 831.66 Mn | - | 779,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 779,000.00 |
| Mar 31, 2025 | 689,000.00 |
| Dec 31, 2021 | -1.32 Mn |
| Sep 30, 2021 | 251,000.00 |
| Jun 30, 2021 | 1.00 Mn |
| Mar 31, 2021 | 696,000.00 |
| Dec 31, 2020 | 75,000.00 |
| Sep 30, 2020 | 86,000.00 |
| Jun 30, 2020 | 138,000.00 |
| Mar 31, 2020 | 250,000.00 |
| Dec 31, 2019 | 282,000.00 |
| Sep 30, 2019 | 279,000.00 |